Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277 - 300; http://dx.doi.org/10.3322/caac.20073; PMID: 20610543
   PubMed Web of Science ®Google Scholar
• Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46:765 - 81; http://dx.doi.org/10.1016/j.ejca.2009.12.014; PMID: 20116997
   PubMed Web of Science ®Google Scholar
• Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, Park EC, Lee JS. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010; 25:1113 - 21; http://dx.doi.org/10.3346/jkms.2010.25.8.1113; PMID: 20676319
   PubMed Web of Science ®Google Scholar
• Chen HM, Weng YR, Jiang B, Sheng JQ, Zheng P, Yu CG, Fang JY. Epidemiological study of colorectal adenoma and cancer in symptomatic patients in China between 1990 and 2009. J Dig Dis 2011; 12:371 - 8; http://dx.doi.org/10.1111/j.1751-2980.2011.00531.x; PMID: 21955430
   PubMed Web of Science ®Google Scholar
• Rougier P, Mitry E. Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol 2003; 14:Suppl 2 ii3 - 5; http://dx.doi.org/10.1093/annonc/mdg722; PMID: 12810450
   PubMedGoogle Scholar
• Luo Y, Wang L, Wang J. Developing proteomics-based biomarkers for colorectal neoplasms for clinical practice: opportunities and challenges. Proteomics Clin Appl 2013; 7:30 - 41; http://dx.doi.org/10.1002/prca.201200071; PMID: 23255431
   PubMed Web of Science ®Google Scholar
• Andersen V, Holst R, Vogel U. Systematic review: diet-gene interactions and the risk of colorectal cancer. Aliment Pharmacol Ther 2013; 37:383 - 91; http://dx.doi.org/10.1111/apt.12180; PMID: 23216531
   PubMed Web of Science ®Google Scholar
• Bretthauer M, Kalager M. Principles, effectiveness and caveats in screening for cancer. Br J Surg 2013; 100:55 - 65; http://dx.doi.org/10.1002/bjs.8995; PMID: 23212620
   PubMed Web of Science ®Google Scholar
• Sillars-Hardebol AH, Carvalho B, van Engeland M, Fijneman RJ, Meijer GA. The adenoma hunt in colorectal cancer screening: defining the target. J Pathol 2012; 226:1 - 6; http://dx.doi.org/10.1002/path.3012; PMID: 21984228
   PubMed Web of Science ®Google Scholar
• Creeden J, Junker F, Vogel-Ziebolz S, Rex D. Serum tests for colorectal cancer screening. Mol Diagn Ther 2011; 15:129 - 41; http://dx.doi.org/10.1007/BF03256403; PMID: 21766904
   PubMed Web of Science ®Google Scholar
• Church D, Midgley R, Kerr D. Biomarkers in early-stage colorectal cancer: ready for prime time?. Dig Dis 2012; 30:Suppl 2 27 - 33; http://dx.doi.org/10.1159/000341890; PMID: 23207929
   PubMedGoogle Scholar
• Sclafani F, Gullo G, Sheahan K, Crown J. BRAF mutations in melanoma and colorectal cancer: a single oncogenic mutation with different tumour phenotypes and clinical implications. Crit Rev Oncol Hematol 2013; 87:55 - 68; http://dx.doi.org/10.1016/j.critrevonc.2012.11.003; PMID: 23246082
   PubMed Web of Science ®Google Scholar
• Terrin L, Rampazzo E, Pucciarelli S, Agostini M, Bertorelle R, Esposito G, DelBianco P, Nitti D, De Rossi A. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. Clin Cancer Res 2008; 14:7444 - 51; http://dx.doi.org/10.1158/1078-0432.CCR-08-0478; PMID: 19010861
   PubMed Web of Science ®Google Scholar
• Wheeler JM. Epigenetics, mismatch repair genes and colorectal cancer. Ann R Coll Surg Engl 2005; 87:15 - 20; http://dx.doi.org/10.1308/1478708051423; PMID: 15720901
   PubMed Web of Science ®Google Scholar
• Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000; 60:6116 - 33; PMID: 11085536
   PubMed Web of Science ®Google Scholar
• Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, et al. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Res 2004; 64:6438 - 43; http://dx.doi.org/10.1158/0008-5472.CAN-03-3869; PMID: 15374952
   PubMed Web of Science ®Google Scholar
• Otani S, Takeda S, Yamada S, Sakakima Y, Sugimoto H, Nomoto S, Kasuya H, Kanazumi N, Nagasaka T, Nakao A. The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor. J Surg Oncol 2009; 100:358 - 63; http://dx.doi.org/10.1002/jso.21241; PMID: 19274676
   PubMed Web of Science ®Google Scholar
• Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI, Stanbridge EJ, Lung ML. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas. Cancer Lett 2006; 234:184 - 92; http://dx.doi.org/10.1016/j.canlet.2005.03.036; PMID: 15885884
   PubMed Web of Science ®Google Scholar
• Jayachandran G, Ueda K, Wang B, Roth JA, Ji L. NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway. PLoS One 2010; 5:e11994; http://dx.doi.org/10.1371/journal.pone.0011994; PMID: 20700484
   PubMedGoogle Scholar
• Ueda K, Kawashima H, Ohtani S, Deng WG, Ravoori M, Bankson J, Gao B, Girard L, Minna JD, Roth JA, et al. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res 2006; 66:9682 - 90; http://dx.doi.org/10.1158/0008-5472.CAN-06-1483; PMID: 17018626
   PubMed Web of Science ®Google Scholar
• Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C, Xu K, Yen N, Atkinson EN, Fang B, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 2002; 62:2715 - 20; PMID: 11980673
   PubMed Web of Science ®Google Scholar
• Schenk PW, Brok M, Boersma AW, Brandsma JA, Den Dulk H, Burger H, Stoter G, Brouwer J, Nooter K. Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill. Mol Pharmacol 2003; 64:259 - 68; http://dx.doi.org/10.1124/mol.64.2.259; PMID: 12869630
   PubMed Web of Science ®Google Scholar
• Yogurtcu B, Hatemi I, Aydin I, Buyru N. NPRL2 gene expression in the progression of colon tumors. Genet Mol Res 2012; 11:4810 - 6; http://dx.doi.org/10.4238/2012.September.12.3; PMID: 23079973
   PubMed Web of Science ®Google Scholar
• Xi L, Nicastri DG, El-Hefnawy T, Hughes SJ, Luketich JD, Godfrey TE. Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin Chem 2007; 53:1206 - 15; http://dx.doi.org/10.1373/clinchem.2006.081828; PMID: 17525108
   PubMed Web of Science ®Google Scholar
• Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D’Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, et al. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Cancer Res 2001; 61:2523 - 32; PMID: 11289125
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17:1471 - 4; http://dx.doi.org/10.1245/s10434-010-0985-4; PMID: 20180029
   PubMed Web of Science ®Google Scholar
• Yang XB, Zhao JJ, Huang CY, Wang QJ, Pan K, Wang DD, Pan QZ, Jiang SS, Lv L, Gao X, et al. Decreased expression of the FOXO3a gene is associated with poor prognosis in primary gastric adenocarcinoma patients. PLoS One 2013; 8:e78158; http://dx.doi.org/10.1371/journal.pone.0078158; PMID: 24194912
   PubMedGoogle Scholar